Condition
Relapsed or Refractory Acute Myeloid Leukemia clinical trials and research
As of November 12, 2026, Find a Trial lists 2 Relapsed or Refractory Acute Myeloid Leukemia clinical trials that are recruiting, in China. By phase: Phase 2 (1). Every study is explained in plain English. Data from ClinicalTrials.gov and NIH RePORTER, updated November 12, 2026.
- 2Clinical trials
- 1Country
All recruiting trials (2)
-
VCC combination in relapsed or refractory AML
A group of adults with relapsed or refractory AML will receive a three-drug combo (venetoclax, chidamide, and chiglitazar sodium) to see if it helps control the leukemia.
-
Using TBI and BUMEL for Stem Cell Transplant in AML Patients
This study is testing a new treatment plan using total body radiation and BUMEL to see if it helps young and middle-aged adults with tough cases of acute myeloid leukemia who need a stem cell transplant.
Quick answers
How many Relapsed or Refractory Acute Myeloid Leukemia clinical trials are recruiting right now?
2, as of November 12, 2026. We update this list each time we refresh our data from ClinicalTrials.gov.
Where are these trials running?
All of them have sites in China. Each study page lists its sites and which ones are recruiting.
What phases are they in?
Phase 2: 1. Trials with no phase listed are usually device, behavioural or observational studies.
How do I join one?
Open a study, check the "Is this trial a fit for you?" section, then contact the study team listed on the page. They will ask a few screening questions. Asking is free and does not commit you to anything. Talk it over with your doctor first.
Find the studies that fit you
A list is a starting point. Tell us your situation in your own words and we'll rank the studies that match and explain why. It's free and needs no account.